Functional analysis of CD8+ T cell responses to the onconeural self protein cdr2 in patients with paraneoplastic cerebellar degeneration

Journal of Neuroimmunology

Volumn 193, Issue 1-2, 2008, Pages 173-182

  Carpenter, Erica L ^a   Vance, Barbara A ^a   Klein, Rachel S ^a   Voloschin, Alfredo ^b   Dalmau, Josep ^c   Vonderheide, Robert H ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cancer; Cerebellar degeneration related antigen 2; Paraneoplastic cerebellar degeneration; T lymphocyte

Indexed keywords

CD8 ANTIGEN; CEREBELLAR DEGENERATION RELATED ANTIGEN 2; EPITOPE; ONCOPROTEIN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NORMAL HUMAN; PARANEOPLASTIC NEUROPATHY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADULT; AGED; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HLA-A2 ANTIGEN; HUMANS; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MIDDLE AGED; NERVE TISSUE PROTEINS; PARANEOPLASTIC CEREBELLAR DEGENERATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 37749029086     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.10.014     Document Type: Article

References (40)

1. Albert M.L., and Darnell R.B. Paraneoplastic neurological degenerations: keys to tumour immunity. Nat. Rev. Cancer. 4 (2004) 36-44
2. Albert M.L., Darnell J.C., Bender A., Francisco L.M., Bhardwaj N., and Darnell R.B. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat. Med. 4 (1998) 1321-1324
3. Albert M.L., Austin L.M., and Darnell R.B. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann. Neurol. 47 (2000) 9-17
4. Bednarek M.A., Sauma S.Y., Gammon M.C., Porter G., Tamhankar S., Williamson A.R., and Zweerink H.J. The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2. J. Immunol. 147 (1991) 4047-4053
5. + T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281 (2003) 65-78
6. + T cells. Blood 107 (2006) 4781-4789
7. Bodinier M., Peyrat M.A., Tournay C., Davodeau F., Romagne F., Bonneville M., and Lang F. Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding. Nat. Med. 6 (2000) 707-710
8. Corradi J.P., Yang C., Darnell J.C., Dalmau J., and Darnell R.B. A post-transcriptional regulatory mechanism restricts expression of the paraneoplastic cerebellar degeneration antigen cdr2 to immune privileged tissues. J. Neurosci. 17 (1997) 1406-1415
9. Corriveau R.A., Huh G.S., and Shatz C.J. Regulation of class I MHC gene expression in the developing and mature CNS by neural activity. Neuron 21 (1998) 505-520
10. Coughlin C.M., Fleming M.D., Carroll R.G., Pawel B.R., Hogarty M.D., Shan X., Vance B.A., Cohen J.N., Jairaj S., Lord E.M., Wexler M.H., Danet-Desnoyers G.A., Pinkus J.L., Pinkus G.S., Maris J.M., Grupp S.A., and Vonderheide R.H. Immunosurveillance and survivin-specific T-cell immunity in children with high-risk neuroblastoma. J. Clin. Oncol. 24 (2006) 5725-5734
11. Cunningham J., Graus F., Anderson N., and Posner J.B. Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration. Neurology 36 (1986) 1163-1168
12. Dalmau J., Furneaux H.M., Cordon-Cardo C., and Posner J.B. The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am. J. Pathol. 141 (1992) 881-886
13. Darnell R.B., and Posner J.B. Paraneoplastic syndromes involving the nervous system. N. Engl. J. Med. 349 (2003) 1543-1554
14. Darnell J.C., Albert M.L., and Darnell R.B. Cdr2, a target antigen of naturally occuring human tumor immunity, is widely expressed in gynecological tumors. Cancer Res. 60 (2000) 2136-2139
15. Fathallah-Shaykh H., Wolf S., Wong E., Posner J.B., and Furneaux H.M. Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 3451-3454
16. Furneaux H.M., Rosenblum M.K., Dalmau J., Wong E., Woodruff P., Graus F., and Posner J.B. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N. Engl. J. Med. 322 (1990) 1844-1851
17. Giometto B., Marchiori G.C., Nicolao P., Scaravilli T., Lion A., Bardin P.G., and Tavolato B. Sub-acute cerebellar degeneration with anti-Yo autoantibodies: immunohistochemical analysis of the immune reaction in the central nervous system. Neuropathol. Appl. Neurobiol. 23 (1997) 468-474
18. Graus F., Illa I., Agusti M., Ribalta T., Cruz-Sanchez F., and Juarez C. Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model. J. Neurol. Sci. 106 (1991) 82-87
19. Graus F., Vega F., Delattre J.Y., Bonaventura I., Rene R., Arbaiza D., and Tolosa E. Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology 42 (1992) 536-540
20. Kannagi M., Shida H., Igarashi H., Kuruma K., Murai H., Aono Y., Maruyama I., Osame M., Hattori T., Inoko H., et al. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells. J. Virol. 66 (1992) 2928-2933
21. Liu S., Mezrich J., Berk J., Federici M., Dalmau J., and Posner J.B. Expression of Purkinje-cell antigens in ovarian tumor, and presence of anti-Purkinje cell antibodies in the serum of patients without paraneoplastic cerebellar degeneration. Neurology 45 Suppl 4 (1995) A228-A229
22. + virus-specific cytotoxic T lymphocytes. J. Med. Virol. 43 (1994) 103-110
23. Molldrem J.J., Lee P.P., Kant S., Wieder E., Jiang W., Lu S., Wang C., and Davis M.M. Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells. J. Clin. Invest. 111 (2003) 639-647
24. Monstad S.E., Storstein A., Dorum A., Knudsen A., Lonning P.E., Salvesen H.B., Aarseth J.H., and Vedeler C.A. Yo antibodies in ovarian and breast cancer patients detected by a sensitive immunoprecipitation technique. Clin Exp Immunol 144 (2006) 53-58
25. Okano H.J., Park W.Y., Corradi J.P., and Darnell R.B. The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival. Genes Dev. 13 (1999) 2087-2097
26. Peterson K., Rosenblum M.K., Kotanides H., and Posner J.B. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 42 (1992) 1931-1937
27. Rubio V., Stuge T.B., Singh N., Betts M.R., Weber J.S., Roederer M., and Lee P.P. Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat. Med. 9 (2003) 1377-1382
28. Rubio-Godoy V., Dutoit V., Rimoldi D., Lienard D., Lejeune F., Speiser D., Guillaume P., Cerottini J.C., Romero P., and Valmori D. Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 10302-10307
29. Saiki M., Sakai K., Saiki S., Kitagawa Y., Nakanishi M., and Hirose G. Induction of humoral responses specific for paraneoplastic cerebellar degeneration-associated antigen by whole recombinant yeast immunization. J Autoimmun 24 (2005) 203-208
30. Sakai K., Mitchell D.J., Tsukamoto T., and Steinman L. Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration. Ann. Neurol. 30 (1991) 738
31. Sakai K., Gofuku M., Kitagawa Y., Ogasawara T., and Hirose G. Induction of anti-Purkinje cell antibodies in vivo by immunizing with a recombinant 52-kDa paraneoplastic cerebellar degeneration-associated protein. J. Neuroimmunol. 60 (1995) 135-141
32. Sakai K., Shirakawa T., Kitagawa Y., Li Y., and Hirose G. Induction of cytotoxic T lymphocytes specific for paraneoplastic cerebellar degeneration-associated antigen in vivo by DNA immunization. J. Autoimmun. 17 (2001) 297-302
33. Schlienger K., Chu C.S., Woo E.Y., Rivers P.M., Toll A.J., Hudson B., Maus M.V., Riley J.L., Choi Y., Coukos G., Kaiser L.R., Rubin S.C., Levine B.L., Carroll R.G., and June C.H. TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients. Clin. Cancer. Res. 9 (2003) 1517-1527
34. Shams'ili S., Grefkens J., de Leeuw B., van den Bent M., Hooijkaas H., van der Holt B., Vecht C., and Sillevis Smitt P. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 126 (2003) 1409-1418
35. Sutton I.J., Steele J., Savage C.O., Winer J.B., and Young L.S. An interferon-gamma ELISPOT and immunohistochemical investigation of cytotoxic T lymphocyte-mediated tumour immunity in patients with paraneoplastic cerebellar degeneration and anti-Yo antibodies. J. Neuroimmunol. 150 (2004) 98-106
36. Tanaka M., Tanaka K., Onodera O., and Tsuji S. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss. Clin. Neurol. Neurosurg. 97 (1995) 95-100
37. Tanaka M., Tanaka K., Tsuji S., Kawata A., Kojima S., Kurokawa T., Kira J., and Takiguchi M. Cytotoxic T cell activity against the peptide, AYRARALEL, from Yo protein of patients with the HLA A24 or B27 supertype and paraneoplastic cerebellar degeneration. J. Neurol. Sci. 188 (2001) 61-65
38. Verschuuren J., Chuang L., Rosenblum M.K., Lieberman F., Pryor A., Posner J.B., and Dalmau J. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration. Acta Neuropathol. (Berl) 91 (1996) 519-525
39. Vonderheide R.H., Hahn W.C., Schultze J.L., and Nadler L.M. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity 10 (1999) 673-679
40. Zhang L., Conejo-Garcia J.R., Katsaros D., Gimotty P.A., Makrigiannakis A., Gray H., Schlienger K., Liebman M.N., Rubin S.C., and Coukos G. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. New Engl. J. Med. 348 (2003) 201-211